Fukuda Denshi Co., Ltd. Stock

Equities

6960

JP3806000000

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange 02:00:00 2024-06-21 EDT 5-day change 1st Jan Change
6,900 JPY +5.50% Intraday chart for Fukuda Denshi Co., Ltd. +15.58% -6.38%

Financials

Sales 2025 * 140B 876M 1.2B Sales 2026 * 144B 901M 1.23B Capitalization 199B 1.24B 1.7B
Net income 2025 * 16.6B 104M 142M Net income 2026 * 17.9B 112M 153M EV / Sales 2025 * 0.96 x
Net cash position 2025 * 63.9B 400M 547M Net cash position 2026 * 71B 444M 608M EV / Sales 2026 * 0.89 x
P/E ratio 2025 *
12 x
P/E ratio 2026 *
11.1 x
Employees 3,382
Yield 2025 *
2.75%
Yield 2026 *
2.97%
Free-Float 53.3%
More Fundamentals * Assessed data
Dynamic Chart
Japanese Stocks Rebound Following Wall Street Rally MT
Fukuda Denshi's Attributable Profit Up 8.2% in Fiscal 2024 MT
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2025 CI
Fukuda Denshi Co., Ltd. Announces Year End Extra Dividend for the Year Ended March 31, 2024, Payable on June 28, 2024; Provides Extra Dividend Guidance for the End of Second Quarter and Year Ending March 31, 2025 CI
Fukuda Denshi Co., Ltd. Provides Ordinary Dividend Guidance for the Second Quarter-End and Fiscal Year Ending March 31, 2025 CI
Fukuda Denshi Co., Ltd. Announces Dividend for the Year Ending March 31, 2024, Payable on June 28, 2024 CI
Fukuda Denshi Co., Ltd Announces Notice on Shareholder Proposal CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Announces Special Dividend for the Year Ended March 31, 2024 CI
Fukuda Denshi Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Provides Special Dividend Guidance for the Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Senzime Licensee Fukuda Denshi Launches Integrated Tetragraph Module in Japanese Market CI
More news
1 day+5.50%
1 week+15.58%
Current month+11.65%
1 month+10.58%
3 months+1.92%
6 months-5.22%
Current year-6.38%
More quotes
1 week
5 770.00
Extreme 5770
6 920.00
1 month
5 770.00
Extreme 5770
6 920.00
Current year
5 770.00
Extreme 5770
8 740.00
1 year
4 385.00
Extreme 4385
8 740.00
3 years
3 470.00
Extreme 3470
8 740.00
5 years
3 180.00
Extreme 3180
8 740.00
10 years
2 725.00
Extreme 2725
8 740.00
More quotes
Managers TitleAgeSince
President 72 80-03-31
Chairman 79 68-03-31
Director/Board Member 55 98-02-28
Members of the board TitleAgeSince
Director/Board Member 74 22-05-31
Chairman 79 68-03-31
Director/Board Member 69 78-06-30
More insiders
Date Price Change Volume
24-06-21 6,900 +5.50% 153,400
24-06-20 6,540 +8.46% 105,600
24-06-19 6,030 +0.84% 10,500
24-06-18 5,980 +2.05% 14,100
24-06-17 5,860 -1.84% 29,700

Delayed Quote Japan Exchange, June 21, 2024 at 02:00 am

More quotes
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
6,900 JPY
Average target price
6,600 JPY
Spread / Average Target
-4.35%
Consensus